tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
Comparison · Analytics
CRediTas vs DoseFinding
A side-by-side editorial comparison of CRediTas and DoseFinding — release velocity, themes, recent moves, and the top alternatives to consider.
CRediTas vs DoseFinding: at a glance
What is CRediTas?
A CRediT author-statement generator that renamed itself, then went quiet for two years.
CRediTas turns a contributor-roles table into a CRediT Author Statement for a paper. The 0.2.0 release in April 2023 did the heavy lifting — package rename, a full object_verb() API rename, and output that drops straight into R Markdown or Quarto. The 0.3.0 release in August 2025 is the only activity since and carries no changelog text beyond a pointer to NEWS.md.
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
CRediTas vs DoseFinding: editorial side-by-side
CRediTas
0.0ANALYTICS
A CRediT author-statement generator that renamed itself, then went quiet for two years.
◆ Current state
CRediTas turns a contributor-roles table into a CRediT Author Statement for a paper. The 0.2.0 release in April 2023 did the heavy lifting — package rename, a full object_verb() API rename, and output that drops straight into R Markdown or Quarto. The 0.3.0 release in August 2025 is the only activity since and carries no changelog text beyond a pointer to NEWS.md.
◆ Where it's heading
Development front-loaded a breaking cleanup during rOpenSci review and has coasted since. The design bet made in 0.2.0 — return a string for inline use rather than write a file — pointed the package at literate authoring workflows rather than at standalone scripts, and nothing since has moved away from it. The empty 0.3.0 note makes the current direction impossible to read from the feed.
◆ Prediction
Too little is published to call the next move; the 0.3.0 entry would need to carry its actual changes for the trajectory to be readable from the changelog at all.
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
Alternatives to CRediTas and DoseFinding
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either CRediTas or DoseFinding.
Tplyr
Tplyr made clinical summary tables explain where every number came from.
rlistings
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
hoardr
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
riem
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
See all CRediTas alternatives → · See all DoseFinding alternatives →
Recent activity from CRediTas and DoseFinding
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 11mo agoCRediTasVersion 0.3.0
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agoDoseFindingCompliance update for R-devel
- 3y agoDoseFindingpowMCTBinCount bug fix
- 3y agoCRediTasZenodo release (version 0.2.0)
- 3y agoCRediTasPackage and every function renamed; output goes inline ⚡
Frequently asked questions
What is the difference between CRediTas and DoseFinding?
They serve adjacent needs but don't currently overlap on shipped themes. CRediTas and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is CRediTas better than DoseFinding?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. CRediTas and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to CRediTas?
Top CRediTas alternatives in Analytics are ranked by recent ship velocity. Browse the "CRediTas alternatives" section above for the current picks, or visit /alternatives/creditas for the full list with editorial commentary on each.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.